Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.47 |
| ▸ | SI | P14410 | 1/20 | 0.47 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.42 |
| ▸ | NOS2 | P35228 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7011395 | 0.83 | ALOX15 (0.51) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL14902188 | 0.83 | GAA (0.48) | ALOX15GAATDP1POLBTSHR | |
| SCHEMBL8892219 | 0.82 | ALOX15 (0.50) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL16653372 | 0.82 | ALOX15 (0.50) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL11191041 | 0.82 | ALOX15 (0.56) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL11191103 | 0.80 | ALOX15 (0.54) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL9527006 | 0.80 | ALOX15 (0.54) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL1219954 | 0.80 | GAA (0.65) | GAATDP1POLBTSHRALDH1A1 | |
| SCHEMBL12496081 | 0.79 | ALOX15 (0.53) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL5203267 | 0.79 | ALOX15 (0.53) | ALOX15GAAMGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3059239-B1 | SULFUR-CONTAINING BICYCLIC COMPOUND | ASTELLAS PHARMA INC (JP) | 2018-06-27 | — | — | EP | disclosed |
| EP-3059239-B1 | SULFUR-CONTAINING BICYCLIC COMPOUND | ASTELLAS PHARMA INC (JP) | 2018-06-27 | — | — | EP | disclosed |
| US-9642852-B2 | Sulfur-containing bicyclic compound | ASTELLAS PHARMA INC. (JP) | 2017-05-09 | — | — | US | disclosed |
| US-9642852-B2 | Sulfur-containing bicyclic compound | ASTELLAS PHARMA INC. (JP) | 2017-05-09 | — | — | US | disclosed |
| EP-3059239-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | Astellas Pharma Inc. (JP) | 2016-08-24 | — | — | EP | disclosed |
| EP-3059239-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | Astellas Pharma Inc. (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-20150231138-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | ASTELLAS PHARMA INC. (JP) | 2015-08-20 | — | — | US | disclosed |
| US-20150231138-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | ASTELLAS PHARMA INC. (JP) | 2015-08-20 | — | — | US | disclosed |
| US-9051339-B2 | Sulfur-containing bicyclic compound | ASTELLAS PHARMA INC. (JP) | 2015-06-09 | — | — | US | disclosed |
| US-9051339-B2 | Sulfur-containing bicyclic compound | ASTELLAS PHARMA INC. (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20150111876-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | ASTELLAS PHARMA INC. (JP) | 2015-04-23 | — | — | US | disclosed |
| US-20150111876-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | ASTELLAS PHARMA INC. (JP) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150111876-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | GABRB1, GABRA1, GABBR1 | ALOX15 3761/4885GAA 1618/4885MGAM 4048/4885 |
| US-20150231138-A1 | SULFUR-CONTAINING BICYCLIC COMPOUND | GABBR1, GABRB1, GRIN2C | ALOX15 3166/4885GAA 2600/4885MGAM 4579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.